Choosing The Right Outsourcing Model (CRO vs. CDMO vs. FSP)
Source: Outsourced Pharma
Many pharma companies are shifting from one-off, fee-for-service deals to deeper long-term partnerships with their CDMOs, emphasizing shared goals and transparency. In this episode, editorial board members Doug Bakan and Kim Burson discuss how to transform the sponsor-CDMO dynamic.